Abstract
Louping ill disease is a zoonotic viral disease caused by louping ill virus in the genus Flavivirus. It belongs to the tick-borne
flavivirus that is a part of the tick-borne encephalitis virus complex.The envelope E protein of louping ill virus is the major
structural protein that plays an important role in membrane binding and inducing a protective immune response.The aim
of the present study was to design multi epitopes vaccine from the envelope E glycoprotein against louping ill virus using
immunoinformatic tools that elicited humoral and cellular immunity. Eighteen envelope E protein sequences were retrieved
from NCBI and subjected to various immunoinformatics tools from IEDB to assess their conservancy, surface accessibility
and antigenicity as promising epitopes against B cells. The binding affinity of the conserved predicted epitopes was analyzed
against MHC-I and MHC-II alleles of the T cells. The predicted epitopes were further assessed for their population coverage.
For B-cell 25, 18 and 12 epitopes were predicted as linear conserved epitopes, surface accessibility and antigenic respectively.
However, nine epitopes overlapped all the B cell prediction tools. Among them three epitopes (205-TAEHLP-210,336-KPCR-339
and 349-SPDV-352) were proposed as B cell epitopes. For T cell, 75 epitopes were found to interact with MHC-I alleles. The
epitopes 130-YVYDANKV-138and356-MLITPNPTI-364 were proposed as a peptide vaccine since they interacted with the highest
number of MHC-1 alleles.Moreover a total of 195core epitopes were found to interact with MHC-II alleles. The core epitopes
130-YVYDANKV-138, 219-WFNDLALPW-227, 415-VIGEHAWDF-423 and 462-VALAWLGLN-470 interacted with higher
number of MHC-II alleles and proposed as vaccine since they demonstrated high affinity to MHC-II alleles.The population
coverage epitopes set for MHC-I and MHC-II alleles was 74.69% and 99.98%, respectively. While the epitopes set for all T cell,
proposed epitopes was 100%. Nine epitopes were predicted eliciting B and T cells and proposed as vaccine candidates against
louping ill virus. However, these proposed epitopes require clinical trials studies to ensure their efficacy as vaccine candidates.
Reference38 articles.
1. 1. Spickler, Rovid A (2009) Ovine Encephalomyelitis; Infectious
2. Encephalomyelitis ague Sheep. The Center of Food Security
3. and Puplic Health 2009: 1-4
4. 2. Westawaye GE, Brinton MA, Gaidamovichs SYa, MC Horzinek,
5. A Igarashi, et al. (1985) Flaviviridae. Intervirology 24: 183-192.